(Q34585404)

3 August 2017

1 reference

title

Statistical issues--significantly important in medical research (English)

1 reference

3 August 2017

0 references

Gellerstedt M

1

1 reference

3 August 2017

publication date

1 February 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

57

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

76-82

1 reference

Statistics in medical journals.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Statistics in medical journals: Developments in the 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

The scandal of poor medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Use of statistical analysis in the New England Journal of Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Rational therapy in the neurosciences: the role of the randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Surrogate endpoints in clinical trials: definition and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Regression towards the mean

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Some examples of regression towards the mean

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Methods for assessing whether change depends on initial value

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Minimization: A new method of assigning patients to treatment and control groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Explaining and Exploiting Placebo Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Ascorbic acid for the common cold. A prophylactic and therapeutic trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Bias in analytic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Statistical methodologies useful for the analysis of data from risk-assessment studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

A comparison of observational studies and randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Statistics notes: Absence of evidence is not evidence of absence

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Statistical power, sample size, and their reporting in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Meta-analyses of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

How to deal with regression to the mean in intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

Study design in perinatal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

7 January 2021

A classification for biomedical research reports

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

7 January 2021

A collection of 56 topics with contradictory results in case-control research

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

1 reference

7 January 2021

Multiple testing in clinical trials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

7 January 2021

The analysis of multiple endpoints in clinical trials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.1R151.X

7 January 2021

10.1034/J.1398-9995.2002.1R151.X

Identifiers

DOI

1 reference

3 August 2017

1 reference